Provided by Tiger Trade Technology Pte. Ltd.

Pacific Biosciences of California

1.56
+0.04002.63%
Pre-market: 1.560.00000.00%05:31 EST
Volume:5.16M
Turnover:8.19M
Market Cap:470.98M
PE:-0.86
High:1.65
Open:1.57
Low:1.55
Close:1.52
52wk High:2.73
52wk Low:0.8511
Shares:301.91M
Float Shares:298.17M
Volume Ratio:0.85
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8215
EPS(LYR):-1.8215
ROE:-213.45%
ROA:-33.73%
PB:88.05
PE(LYR):-0.86

Loading ...

PacBio to Collaborate With n-Lorem Foundation and EspeRare on Precision Therapies for Rare Diseases

Reuters
·
Jan 12

PacBio Reports Preliminary 2025 Revenue of $160 Million with 4% Year-Over-Year Growth

Reuters
·
Jan 12

PacBio HiFi Sequencing Adopted as First-Line Tool for SUDC Research

Reuters
·
Jan 12

Pacific Biosciences of California Inc - Announces Prelim Q4 2025 Revenue of $44.6 Mln

THOMSON REUTERS
·
Jan 12

Pacbio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue

THOMSON REUTERS
·
Jan 12

PacBio Unveils CiFi Method for Chromosome-Scale Genome Assemblies in Single Sequencing Run

Reuters
·
Jan 08

Cathie Wood's Biotech Trend: Twist, Beam, CRISPR Latest Stock Picks

Benzinga_recent_news
·
Jan 01

Pacific Biosciences Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Dec 16, 2025

Pacific Biosciences Is Maintained at Neutral by Piper Sandler

Dow Jones
·
Nov 12, 2025

Pacific Biosciences Is Maintained at Overweight by Stephens & Co.

Dow Jones
·
Nov 10, 2025

How China’s Landmark Genomics Approval Has Changed Pacific Biosciences’ (PACB) Investment Story

Simply Wall St.
·
Nov 07, 2025

Stock Track | Pacific Biosciences Plummets 11.75% Pre-Market Following Mixed Q3 Results and Cash Concerns

Stock Track
·
Nov 06, 2025

Stock Track | Pacific Biosciences Plunges 8.62% After Hours on Mixed Q3 Results and Revenue Decline

Stock Track
·
Nov 06, 2025

Stock Track | Pacific Biosciences Plunges 8.62% After Hours on Mixed Q3 Results and Revenue Decline

Stock Track
·
Nov 06, 2025

Pacific Biosciences of California Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 06, 2025

Stock Track | Pacific Biosciences Shares Plunge 6% After Hours on Mixed Q3 Results and Revenue Decline

Stock Track
·
Nov 06, 2025

Pacific Biosciences of California Q3 EPS USD -0.13

Reuters
·
Nov 06, 2025

PacBio announces publication of new preprint on HiFi sequencing

TIPRANKS
·
Nov 05, 2025

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

GlobeNewswire
·
Nov 04, 2025

Pacific Biosciences of California Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
Nov 04, 2025